Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study
The COVID-19 pandemic has caused a profound change in health organizations at both the primary and hospital care levels. This cross-sectional study aims to investigate the impact of the COVID-19 pandemic in the annual rate of new cancer diagnosis in two university-affiliated hospitals. This study in...
Gespeichert in:
| Veröffentlicht in: | Cancers 2021-06, Vol.13 (13), p.3215 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 13 |
| container_start_page | 3215 |
| container_title | Cancers |
| container_volume | 13 |
| creator | Ruiz-Medina, Sofía Gil, Silvia Jimenez, Begoña Rodriguez-Brazzarola, Pablo Diaz-Redondo, Tamara Cazorla, Mireya Muñoz-Ayllon, Marta Ramos, Inmaculada Reyna, Carmen Bermejo, María José Godoy, Ana Torres, Esperanza Cobo, Manuel Galvez, Laura Rueda, Antonio Alba, Emilio Ribelles, Nuria |
| description | The COVID-19 pandemic has caused a profound change in health organizations at both the primary and hospital care levels. This cross-sectional study aims to investigate the impact of the COVID-19 pandemic in the annual rate of new cancer diagnosis in two university-affiliated hospitals. This study includes all the patients with a pathological diagnosis of cancer attended in two hospitals in Málaga (Spain) during the first year of pandemic. This study population was compared with the patients diagnosed during the previous year 2019. To analyze whether the possible differences in the annual rate of diagnoses were due to the pandemic or to other causes, the patients diagnosed during 2018 and 2017 were also compared. There were 2340 new cancer diagnosis compared to 2825 patients in 2019 which represented a decrease of -17.2% (
= 0.0001). Differences in the number of cancer patients diagnosed between 2018 and 2019 (2840 new cases; 0.5% increase) or 2017 and 2019 (2909 new cases; 3% increase) were not statistically significant. The highest number of patients lost from diagnosis in 2020 was in breast cancer (-26.1%), colorectal neoplasms (-16.9%), and head and neck tumors (-19.8%). The study of incidence rates throughout the first year of the COVID-19 pandemic shows that the diagnosis of new cancer patients has been significantly impaired. Health systems must take the necessary measures to restore pre-pandemic diagnostic procedures and to recover lost patients who have not been diagnosed. |
| doi_str_mv | 10.3390/cancers13133215 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8267675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2549280119</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-53f72844c2ebcd2fa55dc6ef6003e46dfafe996e826734c99cdd5db27b3b3d313</originalsourceid><addsrcrecordid>eNpdkctL7DAUxoMoKuranQTuxk21eTRt7uLCMOMLBMVRtyFNTmcinXRu0gr-96a-ULNIAuc7v_P4EDok-QljMj812hsIkTDCGCXFBtqleUkzISTf_PbfQQcxPuXpMEZKUW6jHcZpzkhV7KLl3C28a1xi9XgGJoCOgJ3HE-8H3eLpWw08c3rhuwhxDM3XOt12CM4vcL8EPL15vJplROJb7S2snPmLJ_gOdJvNdK_xvB_syz7aanQb4eDj3UMP52f308vs-ubiajq5zgynpM8K1pS04txQqI2ljS4KawQ0InUPXNhGNyClgIqKknEjpbG2sDUta1Yzmzaxh_69c9dDvQJrwPdBt2od3EqHF9Vpp35GvFuqRfesRqIoiwQ4_gCE7v8AsVcrFw20rfbQDVHRglec8LIaa_35JX3qhuDTeKNK0ionRCbV6bvKhC7GAM1XMyRXo5Hql5Ep4-j7DF_6T9vYK645mdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2549280119</pqid></control><display><type>article</type><title>Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Ruiz-Medina, Sofía ; Gil, Silvia ; Jimenez, Begoña ; Rodriguez-Brazzarola, Pablo ; Diaz-Redondo, Tamara ; Cazorla, Mireya ; Muñoz-Ayllon, Marta ; Ramos, Inmaculada ; Reyna, Carmen ; Bermejo, María José ; Godoy, Ana ; Torres, Esperanza ; Cobo, Manuel ; Galvez, Laura ; Rueda, Antonio ; Alba, Emilio ; Ribelles, Nuria</creator><creatorcontrib>Ruiz-Medina, Sofía ; Gil, Silvia ; Jimenez, Begoña ; Rodriguez-Brazzarola, Pablo ; Diaz-Redondo, Tamara ; Cazorla, Mireya ; Muñoz-Ayllon, Marta ; Ramos, Inmaculada ; Reyna, Carmen ; Bermejo, María José ; Godoy, Ana ; Torres, Esperanza ; Cobo, Manuel ; Galvez, Laura ; Rueda, Antonio ; Alba, Emilio ; Ribelles, Nuria</creatorcontrib><description>The COVID-19 pandemic has caused a profound change in health organizations at both the primary and hospital care levels. This cross-sectional study aims to investigate the impact of the COVID-19 pandemic in the annual rate of new cancer diagnosis in two university-affiliated hospitals. This study includes all the patients with a pathological diagnosis of cancer attended in two hospitals in Málaga (Spain) during the first year of pandemic. This study population was compared with the patients diagnosed during the previous year 2019. To analyze whether the possible differences in the annual rate of diagnoses were due to the pandemic or to other causes, the patients diagnosed during 2018 and 2017 were also compared. There were 2340 new cancer diagnosis compared to 2825 patients in 2019 which represented a decrease of -17.2% (
= 0.0001). Differences in the number of cancer patients diagnosed between 2018 and 2019 (2840 new cases; 0.5% increase) or 2017 and 2019 (2909 new cases; 3% increase) were not statistically significant. The highest number of patients lost from diagnosis in 2020 was in breast cancer (-26.1%), colorectal neoplasms (-16.9%), and head and neck tumors (-19.8%). The study of incidence rates throughout the first year of the COVID-19 pandemic shows that the diagnosis of new cancer patients has been significantly impaired. Health systems must take the necessary measures to restore pre-pandemic diagnostic procedures and to recover lost patients who have not been diagnosed.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13133215</identifier><identifier>PMID: 34203185</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Breast cancer ; Cancer therapies ; Colorectal cancer ; Coronaviruses ; COVID-19 ; Diagnosis ; Esophageal cancer ; Hematology ; Hospitals ; Lung cancer ; Medical diagnosis ; Medical screening ; Medicare ; Pandemics ; Patients ; Population ; Population studies ; Prostate ; Statistical analysis ; Tumors</subject><ispartof>Cancers, 2021-06, Vol.13 (13), p.3215</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-53f72844c2ebcd2fa55dc6ef6003e46dfafe996e826734c99cdd5db27b3b3d313</citedby><cites>FETCH-LOGICAL-c421t-53f72844c2ebcd2fa55dc6ef6003e46dfafe996e826734c99cdd5db27b3b3d313</cites><orcidid>0000-0003-3402-1144 ; 0000-0003-3194-7398 ; 0000-0002-5503-6946</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267675/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267675/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34203185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ruiz-Medina, Sofía</creatorcontrib><creatorcontrib>Gil, Silvia</creatorcontrib><creatorcontrib>Jimenez, Begoña</creatorcontrib><creatorcontrib>Rodriguez-Brazzarola, Pablo</creatorcontrib><creatorcontrib>Diaz-Redondo, Tamara</creatorcontrib><creatorcontrib>Cazorla, Mireya</creatorcontrib><creatorcontrib>Muñoz-Ayllon, Marta</creatorcontrib><creatorcontrib>Ramos, Inmaculada</creatorcontrib><creatorcontrib>Reyna, Carmen</creatorcontrib><creatorcontrib>Bermejo, María José</creatorcontrib><creatorcontrib>Godoy, Ana</creatorcontrib><creatorcontrib>Torres, Esperanza</creatorcontrib><creatorcontrib>Cobo, Manuel</creatorcontrib><creatorcontrib>Galvez, Laura</creatorcontrib><creatorcontrib>Rueda, Antonio</creatorcontrib><creatorcontrib>Alba, Emilio</creatorcontrib><creatorcontrib>Ribelles, Nuria</creatorcontrib><title>Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>The COVID-19 pandemic has caused a profound change in health organizations at both the primary and hospital care levels. This cross-sectional study aims to investigate the impact of the COVID-19 pandemic in the annual rate of new cancer diagnosis in two university-affiliated hospitals. This study includes all the patients with a pathological diagnosis of cancer attended in two hospitals in Málaga (Spain) during the first year of pandemic. This study population was compared with the patients diagnosed during the previous year 2019. To analyze whether the possible differences in the annual rate of diagnoses were due to the pandemic or to other causes, the patients diagnosed during 2018 and 2017 were also compared. There were 2340 new cancer diagnosis compared to 2825 patients in 2019 which represented a decrease of -17.2% (
= 0.0001). Differences in the number of cancer patients diagnosed between 2018 and 2019 (2840 new cases; 0.5% increase) or 2017 and 2019 (2909 new cases; 3% increase) were not statistically significant. The highest number of patients lost from diagnosis in 2020 was in breast cancer (-26.1%), colorectal neoplasms (-16.9%), and head and neck tumors (-19.8%). The study of incidence rates throughout the first year of the COVID-19 pandemic shows that the diagnosis of new cancer patients has been significantly impaired. Health systems must take the necessary measures to restore pre-pandemic diagnostic procedures and to recover lost patients who have not been diagnosed.</description><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Colorectal cancer</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Diagnosis</subject><subject>Esophageal cancer</subject><subject>Hematology</subject><subject>Hospitals</subject><subject>Lung cancer</subject><subject>Medical diagnosis</subject><subject>Medical screening</subject><subject>Medicare</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Population</subject><subject>Population studies</subject><subject>Prostate</subject><subject>Statistical analysis</subject><subject>Tumors</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkctL7DAUxoMoKuranQTuxk21eTRt7uLCMOMLBMVRtyFNTmcinXRu0gr-96a-ULNIAuc7v_P4EDok-QljMj812hsIkTDCGCXFBtqleUkzISTf_PbfQQcxPuXpMEZKUW6jHcZpzkhV7KLl3C28a1xi9XgGJoCOgJ3HE-8H3eLpWw08c3rhuwhxDM3XOt12CM4vcL8EPL15vJplROJb7S2snPmLJ_gOdJvNdK_xvB_syz7aanQb4eDj3UMP52f308vs-ubiajq5zgynpM8K1pS04txQqI2ljS4KawQ0InUPXNhGNyClgIqKknEjpbG2sDUta1Yzmzaxh_69c9dDvQJrwPdBt2od3EqHF9Vpp35GvFuqRfesRqIoiwQ4_gCE7v8AsVcrFw20rfbQDVHRglec8LIaa_35JX3qhuDTeKNK0ionRCbV6bvKhC7GAM1XMyRXo5Hql5Ep4-j7DF_6T9vYK645mdg</recordid><startdate>20210628</startdate><enddate>20210628</enddate><creator>Ruiz-Medina, Sofía</creator><creator>Gil, Silvia</creator><creator>Jimenez, Begoña</creator><creator>Rodriguez-Brazzarola, Pablo</creator><creator>Diaz-Redondo, Tamara</creator><creator>Cazorla, Mireya</creator><creator>Muñoz-Ayllon, Marta</creator><creator>Ramos, Inmaculada</creator><creator>Reyna, Carmen</creator><creator>Bermejo, María José</creator><creator>Godoy, Ana</creator><creator>Torres, Esperanza</creator><creator>Cobo, Manuel</creator><creator>Galvez, Laura</creator><creator>Rueda, Antonio</creator><creator>Alba, Emilio</creator><creator>Ribelles, Nuria</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3402-1144</orcidid><orcidid>https://orcid.org/0000-0003-3194-7398</orcidid><orcidid>https://orcid.org/0000-0002-5503-6946</orcidid></search><sort><creationdate>20210628</creationdate><title>Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study</title><author>Ruiz-Medina, Sofía ; Gil, Silvia ; Jimenez, Begoña ; Rodriguez-Brazzarola, Pablo ; Diaz-Redondo, Tamara ; Cazorla, Mireya ; Muñoz-Ayllon, Marta ; Ramos, Inmaculada ; Reyna, Carmen ; Bermejo, María José ; Godoy, Ana ; Torres, Esperanza ; Cobo, Manuel ; Galvez, Laura ; Rueda, Antonio ; Alba, Emilio ; Ribelles, Nuria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-53f72844c2ebcd2fa55dc6ef6003e46dfafe996e826734c99cdd5db27b3b3d313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Colorectal cancer</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Diagnosis</topic><topic>Esophageal cancer</topic><topic>Hematology</topic><topic>Hospitals</topic><topic>Lung cancer</topic><topic>Medical diagnosis</topic><topic>Medical screening</topic><topic>Medicare</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Population</topic><topic>Population studies</topic><topic>Prostate</topic><topic>Statistical analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ruiz-Medina, Sofía</creatorcontrib><creatorcontrib>Gil, Silvia</creatorcontrib><creatorcontrib>Jimenez, Begoña</creatorcontrib><creatorcontrib>Rodriguez-Brazzarola, Pablo</creatorcontrib><creatorcontrib>Diaz-Redondo, Tamara</creatorcontrib><creatorcontrib>Cazorla, Mireya</creatorcontrib><creatorcontrib>Muñoz-Ayllon, Marta</creatorcontrib><creatorcontrib>Ramos, Inmaculada</creatorcontrib><creatorcontrib>Reyna, Carmen</creatorcontrib><creatorcontrib>Bermejo, María José</creatorcontrib><creatorcontrib>Godoy, Ana</creatorcontrib><creatorcontrib>Torres, Esperanza</creatorcontrib><creatorcontrib>Cobo, Manuel</creatorcontrib><creatorcontrib>Galvez, Laura</creatorcontrib><creatorcontrib>Rueda, Antonio</creatorcontrib><creatorcontrib>Alba, Emilio</creatorcontrib><creatorcontrib>Ribelles, Nuria</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ruiz-Medina, Sofía</au><au>Gil, Silvia</au><au>Jimenez, Begoña</au><au>Rodriguez-Brazzarola, Pablo</au><au>Diaz-Redondo, Tamara</au><au>Cazorla, Mireya</au><au>Muñoz-Ayllon, Marta</au><au>Ramos, Inmaculada</au><au>Reyna, Carmen</au><au>Bermejo, María José</au><au>Godoy, Ana</au><au>Torres, Esperanza</au><au>Cobo, Manuel</au><au>Galvez, Laura</au><au>Rueda, Antonio</au><au>Alba, Emilio</au><au>Ribelles, Nuria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2021-06-28</date><risdate>2021</risdate><volume>13</volume><issue>13</issue><spage>3215</spage><pages>3215-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>The COVID-19 pandemic has caused a profound change in health organizations at both the primary and hospital care levels. This cross-sectional study aims to investigate the impact of the COVID-19 pandemic in the annual rate of new cancer diagnosis in two university-affiliated hospitals. This study includes all the patients with a pathological diagnosis of cancer attended in two hospitals in Málaga (Spain) during the first year of pandemic. This study population was compared with the patients diagnosed during the previous year 2019. To analyze whether the possible differences in the annual rate of diagnoses were due to the pandemic or to other causes, the patients diagnosed during 2018 and 2017 were also compared. There were 2340 new cancer diagnosis compared to 2825 patients in 2019 which represented a decrease of -17.2% (
= 0.0001). Differences in the number of cancer patients diagnosed between 2018 and 2019 (2840 new cases; 0.5% increase) or 2017 and 2019 (2909 new cases; 3% increase) were not statistically significant. The highest number of patients lost from diagnosis in 2020 was in breast cancer (-26.1%), colorectal neoplasms (-16.9%), and head and neck tumors (-19.8%). The study of incidence rates throughout the first year of the COVID-19 pandemic shows that the diagnosis of new cancer patients has been significantly impaired. Health systems must take the necessary measures to restore pre-pandemic diagnostic procedures and to recover lost patients who have not been diagnosed.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34203185</pmid><doi>10.3390/cancers13133215</doi><orcidid>https://orcid.org/0000-0003-3402-1144</orcidid><orcidid>https://orcid.org/0000-0003-3194-7398</orcidid><orcidid>https://orcid.org/0000-0002-5503-6946</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2072-6694 |
| ispartof | Cancers, 2021-06, Vol.13 (13), p.3215 |
| issn | 2072-6694 2072-6694 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8267675 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central |
| subjects | Breast cancer Cancer therapies Colorectal cancer Coronaviruses COVID-19 Diagnosis Esophageal cancer Hematology Hospitals Lung cancer Medical diagnosis Medical screening Medicare Pandemics Patients Population Population studies Prostate Statistical analysis Tumors |
| title | Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T18%3A22%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Significant%20Decrease%20in%20Annual%20Cancer%20Diagnoses%20in%20Spain%20during%20the%20COVID-19%20Pandemic:%20A%20Real-Data%20Study&rft.jtitle=Cancers&rft.au=Ruiz-Medina,%20Sof%C3%ADa&rft.date=2021-06-28&rft.volume=13&rft.issue=13&rft.spage=3215&rft.pages=3215-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13133215&rft_dat=%3Cproquest_pubme%3E2549280119%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2549280119&rft_id=info:pmid/34203185&rfr_iscdi=true |